<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
COMMUNITY MEDICAL TRANSPORT, INC.
(Name of Issuer)
Common Stock, $ 0.001 par value
(Title of Class of Securities)
203744107
(CUSIP Number)
Thomas A. Huser, Esq.
Quadrant Management, Inc.
720 5th Avenue, 9th Floor
New York, New York 10019
212-231-3900
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 30, 1998
(Date of Event which Requires Filing
of this Statement
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of
Rule 13d-1 (b)(3) or (4), check the following box / / .
Check the following box if a fee is being paid with this statement / / .
(Continued on following page (s)
Page 1 of 13 Pages
Exhibit Index Appears on Page 5)
<PAGE> 2
CUSIP NO. 203744107 13D Page 2 of 13 Pages
1 NAME OF REPORTING PERSON
SSN OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Herbard Limited (no Fed. I.D. No.)
2 CHECK THE APPROPRIATE BOX IF A MEMBER (a) / /
OF A GROUP. (b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS / /
IS REQUIRED PURSUANT TO ITEMS 2 (d) or 2 (e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands
NUMBER 7 SOLE VOTING POWER 368,200 Shares
OF
WARRANTS
BENEFICIALLY 8 SHARED VOTING POWER NONE
OWNED
BY
EACH 9 SOLE DISPOSITIVE POWER 368,200 Shares
REPORTING
PERSON
WITH 10 SHARED DISPOSITIVE POWER NONE
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 368,200 Shares
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES / /
CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.45%
14 TYPE OF REPORTING PERSON CO
<PAGE> 3
CUSIP NO. 203744107 13D PAGE 3 OF 13 PAGES
Item 1 SECURITY AND ISSUER
This statement on Schedule 13D (the "Amendment"), filed with respect to
events that occurred on September 30, 1998, relates to shares of Common Stock,
par value $0.001 per share, of Community Medical Transport, Inc., a Delaware
corporation (the"Common Stock" and the "Issuer", respectively), whose principal
executive offices are located at 4 Gannett Drive, White Plains, New York, 10604.
Item 2 IDENTITY AND BACKGROUND
This Statement is filed by Herbard Limited, a British Virgin Islands
corporation ("Herbard").
Herbard may be deemed to be controlled by the Phyllis Quasha Revocable
Trust. Phyllis G. Quasha, as the settlor of the Trust, may be deemed to control
the Trust. Based upon the foregoing considerations, for purposes of General
Instruction C to Schedule 13D, the Phyllis Quasha Revocable Trust and Phyllis G.
Quasha (collectively, the "Instruction C Persons") may be deemed to control
Herbard.
Exhibit A sets forth the name, place of organization, principal
business, address of principal business and address of principal office of
Herbard and each Instruction C Person.
The name, citizenship, business address and present principal
occupation or employment of each executive officer and director of Herbard and
each of the Instruction C Persons, as well as the name, principal business and
address of the corporation or other organization in which such occupation or
employment is conducted, are set forth in Exhibit B.
During the five years prior to the date hereof, neither Herbard nor, to
the best of their knowledge, any of the Instruction C Persons or any executive
officer or director of Herbard or any of the Instruction C Persons, (i) have
been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction, as a result of which such person
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
Item 3 SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The funds for purchase by Herbard of the 100,000 shares of Common Stock
purchased on September 30, 1998, an aggregate of $65,953.00, came from the
general corporate funds of Herbard.
<PAGE> 4
CUSIP NO. 203744107 13D Page 4 of 13 Pages
Item 4 PURPOSE OF THE TRANSACTION
On September 30, 1998, Herbard purchased 100,000 shares of Common Stock
in transactions in the over-the-counter market, as part of its short-term
trading and long-term investment activities.
Item 5 INTEREST IN SECURITIES OF THE ISSUER
(a) & (b) As of July,1998, the Issuer had a total of 6,090,683 shares
of Common Stock issued and outstanding according to information made publicly
available by the Issuer.
Pursuant to Rule 13d-3, the Reporting Person may be deemed to
beneficially own an aggregate of 368,200 Shares. Pursuant to Rule 13d-3 (d) (1)
(i), such 368,200 Shares constitute an aggregate of approximately 6.45% of the
outstanding Common Stock.
(c) Other than the transactions described in this Statement and those
described in Exhibit D hereto, no transactions in the shares of Common Stock
have been effected during the past 60 days by Herbard, or, any of the persons
named in Exhibit B.
(d) Inapplicable
(e) Inapplicable
Item 6 Contracts, Arrangements, Understandings or Relationships with respect
to Securities of the Issuer.
Neither Herbard nor, to the best of its knowledge, any executive
officer or director thereof, has any contract, arrangement, understanding or
relationship with one or more security holders of the Issuer or others, with
respect to the purchase, holding, voting or disposition of shares of Common
Stock or other securities of the Issuer which are convertible or exercisable
into such shares. Each of such persons reserves the right to enter into any such
contract, arrangement, understanding or relationship in the future.
<PAGE> 5
CUSIP NO. 203744107 13D Page 5 of 13 Pages
Item 7 Material to be Filed as Exhibits Page
Exhibit A: Information concerning 7
Reporting Persons and Instruction C Persons.
Exhibit B: Information concerning 10
Reporting Persons' and Instruction C Persons' Officers,
Directors and Others.
Exhibit C: Power of Attorney of 12
Herbard Limited granted to Thomas A. Huser.
Exhibit D: Information concerning 13
other shares purchased within the last 60 days.
<PAGE> 6
CUSIP NO. 203744107 13D Page 6 of 13 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: October 7, 1998
HERBARD LIMITED
By: /s/ Thomas A. Huser
Thomas A. Huser
Attorney-in-Fact
<PAGE> 1
CUSIP NO. 203744107 13D Page 7 of 13 Pages
Exhibit A
Name: Herbard Limited
Place of Organization: British Virgin Islands
Principal Business: A holding company
Address of Principal Business: P. O. Box 438
Road Town, Tortola
British Virgin Islands
Address of Principal Office: P. O. Box 438
Road Town, Tortola
British Virgin Islands
<PAGE> 2
CUSIP NO. 203744107 13D Page 8 of 13 Pages
Name: Phyllis Quasha Revocable Trust EXHIBIT A
Place of Organization: Bermuda
Principal Business: A personal trust
Address of Principal Business: c/o Grosvenor Trust Company Limited
Airlie House
33 Church Street
Hamilton, Bermuda
Address of Principal: c/o Grosvenor Trust Company Limited
Airlie House
33 Church Street
Hamilton, Bermuda
<PAGE> 3
CUSIP NO. 203744107 13D Page 9 of 13 Pages
Name: Phyllis Grant Quasha EXHIBIT A
Residence Address: Suite 12
Lyford Cay
Nassau, Bahamas
Principal Occupation: Private Investor
Citizenship: Australia
<PAGE> 1
CUSIP NO. 203744107 13D Page 10 of 13 Pages
EXHIBIT B
HERBARD LIMITED
<TABLE>
<CAPTION>
Position
Name with Company Occupation Principal Address
<S> <C> <C> <C>
SCS Limited Director Management P.O. Box 438
Company Road Town, Tortola
British Virgin Islands
Gordon Howard President Trust Company Grosvenor Trust Company Limited
Executive Airlie House
33 Church Street
Hamilton, Bermuda
Norman Holbrow Vice President Trust Company Grosvenor Trust Company Limited
Executive Airlie House
33 Church Street
Hamilton, Bermuda
Jill Clifford Secretary/ Trust Company Grosvenor Trust Company Limited
Treasurer Executive Airlie House
33 Church Street
Hamilton, Bermuda
</TABLE>
<PAGE> 2
CUSIP No. 203744107 13D Page 11 of 13 Pages
EXHIBIT B
PHYLLIS QUASHA REVOCABLE TRUST
<TABLE>
<CAPTION>
Position
Name with Company Occupation Principal Address
<S> <C> <C> <C>
Grosvenor Trust Corporate Corporate Grosvenor Trust Company Limited
Company Trust Trustee Trustee Airlie House
33 Church Street
Hamilton, Bermuda
Phyllis G. Quasha Settlor Private Suite 12
Investor Lyford Cay
Nassau, Bahamas
</TABLE>
<PAGE> 1
CUSIP NO. 203744107 13D Page 12 of 13 Pages
EXHIBIT C
LIMITED POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS that Herbard Limited (the "Corporation")
does hereby make, constitute and appoint THOMAS A. HUSER as true and lawful
attorney-in-fact of the Corporation, to act in the name, place and stead of the
Corporation.
To negogiate, execute and deliver any and all agreements, documents,
instruments and certificates, and to take any and all actions, of whatever kind,
with regard, directly or indirectly, to any filings, notices, authorizations or
actions required or advisable to be made with, given to, obtained from or
otherwise to comply with the rules and regulations of the Securities and
Exchange Commission, and state or any other governmental office or body, in
connection with the record of beneficial ownership or other interest by the
Corporation of, or any transactions relating in any way to, any securities of
Community Medical Transport, Inc., including, without limitation, (1) any
statements on Schedule 13D and any amendments thereto, (2) any joint filing
agreements pursuant to Rule 13d-1(f) promulgated under the Securities Exchange
Commission Act of 1934, as amended, and any amendments thereto, (3) any initial
statements of beneficial ownership on Form 3, and (4) any statements of Change
in beneficial ownership on Form 4 or Form 5.
Giving and granting unto said attorney-in-fact full power and authority
to do and perform any and every act whatsoever requisite, necessary, or in the
opinion of said attorney-in-fact, desirable to be done in connection with the
foregoing, as fully and to intents and purposes as the undersigned might or
could do if personally present, by its officers, hereby ratifying and confirming
all acts that said attorney-in-fact shall do or cause to be done by virtue
hereof.
The Corporation hereby agrees to indemnify and hold harmless the
attorney-in-fact for any claims, liabilities, costs or expenses, including
reasonable attorney's fees, incurred by said attorney-in-fact arising out of, or
in any way connected with, performance by said attorney-in-fact of any and all
acts duly authorized hereunder by the Corporation unless such claims arise out
of the wilful or grossly negligent disregard by such attorney-in-fact of his
obligation hereunder.
This Power of Attorney shall expire on October 7, 1998
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be duly executed this 7th day of October, 1998.
HERBARD LIMITED
By S.C.S. LIMITED, sole director
<PAGE> 1
By:/s/ Susan Demers
CUSIP NO. 203744107 13D Page 13 of 13 Pages
EXHIBIT D
OTHER PURCHASES OF SHARES WITHIN THE LAST 60 DAYS
<TABLE>
<CAPTION>
Date Number of Shares Price Per Share
<S> <C> <C>
9/09/98 5,000 $.76
9/14/98 10,000 $.67
9/15/98 5,000 $.64
9/16/98 20,000 $.75
9/17/98 5,000 $.76
9/23/98 2,000 $.66
</TABLE>
